These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11314095)
1. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. Alden TD; Beres EJ; Laurent JS; Engh JA; Das S; London SD; Jane JA; Hudson SB; Helm GA J Craniofac Surg; 2000 Jan; 11(1):24-30. PubMed ID: 11314095 [TBL] [Abstract][Full Text] [Related]
3. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149 [TBL] [Abstract][Full Text] [Related]
4. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Alden TD; Pittman DD; Hankins GR; Beres EJ; Engh JA; Das S; Hudson SB; Kerns KM; Kallmes DF; Helm GA Hum Gene Ther; 1999 Sep; 10(13):2245-53. PubMed ID: 10498255 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Dumont RJ; Dayoub H; Li JZ; Dumont AS; Kallmes DF; Hankins GR; Helm GA Neurosurgery; 2002 Nov; 51(5):1239-44; discussion 1244-5. PubMed ID: 12383369 [TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents. Dayoub H; Dumont RJ; Li JZ; Dumont AS; Hankins GR; Kallmes DF; Helm GA Tissue Eng; 2003 Apr; 9(2):347-56. PubMed ID: 12740097 [TBL] [Abstract][Full Text] [Related]
7. Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats. Tang Y; Tang W; Lin Y; Long J; Wang H; Liu L; Tian W Cell Biol Int; 2008 Sep; 32(9):1150-7. PubMed ID: 18638562 [TBL] [Abstract][Full Text] [Related]
8. Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. Ishihara A; Shields KM; Litsky AS; Mattoon JS; Weisbrode SE; Bartlett JS; Bertone AL J Orthop Res; 2008 Jun; 26(6):764-71. PubMed ID: 18241059 [TBL] [Abstract][Full Text] [Related]
9. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562 [TBL] [Abstract][Full Text] [Related]
10. Colocalization of c-Src (pp60src) and bone morphogenetic protein 2/4 expression during mandibular distraction osteogenesis: in vivo evidence of their role within an integrin-mediated mechanotransduction pathway. Rhee ST; Buchman SR Ann Plast Surg; 2005 Aug; 55(2):207-15. PubMed ID: 16034255 [TBL] [Abstract][Full Text] [Related]
11. CT and radionuclide study of BMP-2 gene therapy-induced bone formation. Varady P; Li JZ; Alden TD; Kallmes DF; Williams MB; Helm GA Acad Radiol; 2002 Jun; 9(6):632-7. PubMed ID: 12061736 [TBL] [Abstract][Full Text] [Related]
12. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Li JZ; Li H; Sasaki T; Holman D; Beres B; Dumont RJ; Pittman DD; Hankins GR; Helm GA Gene Ther; 2003 Sep; 10(20):1735-43. PubMed ID: 12939640 [TBL] [Abstract][Full Text] [Related]
13. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Varady P; Li JZ; Cunningham M; Beres EJ; Das S; Engh J; Alden TD; Pittman DD; Kerns KM; Kallmes DF; Helm GA Hum Gene Ther; 2001 Apr; 12(6):697-710. PubMed ID: 11426468 [TBL] [Abstract][Full Text] [Related]
14. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2. Cochran DL; Nummikoski PV; Jones AA; Makins SR; Turek TJ; Buser D Int J Oral Maxillofac Implants; 1997; 12(6):739-48. PubMed ID: 9425754 [TBL] [Abstract][Full Text] [Related]
15. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244 [TBL] [Abstract][Full Text] [Related]
16. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Egermann M; Baltzer AW; Adamaszek S; Evans C; Robbins P; Schneider E; Lill CA Hum Gene Ther; 2006 May; 17(5):507-17. PubMed ID: 16716108 [TBL] [Abstract][Full Text] [Related]
17. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. Lieberman JR; Daluiski A; Stevenson S; Wu L; McAllister P; Lee YP; Kabo JM; Finerman GA; Berk AJ; Witte ON J Bone Joint Surg Am; 1999 Jul; 81(7):905-17. PubMed ID: 10428121 [TBL] [Abstract][Full Text] [Related]
18. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. Helm GA; Alden TD; Beres EJ; Hudson SB; Das S; Engh JA; Pittman DD; Kerns KM; Kallmes DF J Neurosurg; 2000 Apr; 92(2 Suppl):191-6. PubMed ID: 10763690 [TBL] [Abstract][Full Text] [Related]
19. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. Zachos TA; Shields KM; Bertone AL J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180 [TBL] [Abstract][Full Text] [Related]
20. Callus formation enhanced by BMP-7 ex vivo gene therapy during distraction osteogenesis in rats. Hu J; Qi MC; Zou SJ; Li JH; Luo E J Orthop Res; 2007 Feb; 25(2):241-51. PubMed ID: 17089407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]